Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Treatment of primary biliary cholangitis and primary sclerosing cholangitis with baricitinib

US Patent 11197860 · Granted Dec 14, 2021

Estimated economic value: $2,192,198,000

Assignee

Inventors

View full patent text on Google Patents →